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Edited by Sandro SonninoAbstract HepG2 cells, stably transfected with MDR1 cDNA,
encoding the P-glycoprotein multidrug resistance eﬄux pump,
display an altered sphingolipid composition compared to control
cells, stably transfected with empty vector. The MDR1 over-
expressing cells display a 3-fold increased level of lactosylcer-
amide and an increased ganglioside mass. Both the mRNA and
the activity of lactosylceramide synthase were increased in
HepG2/MDR1 cells. In conclusion, the increased glycolipid con-
tent in MDR1-transfected HepG2 cells is caused by a transcrip-
tional up-regulation of the enzyme lactosylceramide synthase.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Treatment failure in cancer is often due to the occurrence of
multidrug resistance (MDR). Numerous MDR mechanisms
exist, including the overexpression of energy-dependent drug
eﬄux proteins, such as P-glycoprotein (Pgp) [1].
Moreover, it has become apparent that sphingolipids and
their metabolism play a role in drug resistance, possibly in con-
cert with ATP-binding cassette (ABC) transporter proteins [2–
4]. Evidence for a relation between MDR and sphingolipids
has come from studies in tumour cell lines, which acquired a
drug resistant phenotype by selection with cytotoxic agents.
The level of glucosylceramide (GlcCer), a precursor of all com-
plex glycosphingolipids and a direct metabolic product of cer-
amide (Cer), was consistently elevated in several MDR1
overexpressing cell lines [5]. A similar GlcCer increase was ob-
served in the multidrug resistance-related protein 1 over-
expressing HT29col cell line [6].Abbreviations: ABC, ATP-binding cassette; Cer, ceramide; CSA, cyc-
losporin A; GlcCer, glucosylceramide; HPTLC, high performance thin
layer chromatography; LacCer, lactosylceramide; Pgp, P-glycoprotein;
SM, sphingomyelin
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doi:10.1016/j.febslet.2005.05.003Little is known concerning the mechanisms underlying
MDR-associated sphingolipid changes, but these may depend
on cell type. It has been suggested that increased conversion of
Cer to GlcCer by glucosylceramide synthase in drug-selected
MDR1 overexpressing MCF-7 cells can rescue cells from
Cer-mediated apoptosis induced by cytostatics [7,8]. On the
other hand, in drug-selected MDR1 overexpressing 2780AD
cells, uncoupling of GlcCer and lactosylceramide (LacCer)
biosynthesis in the Golgi apparatus leads to accumulation of
GlcCer, without changes in glucosylceramide synthase expres-
sion or activity [9]. It is therefore important to explore MDR-
associated changes in sphingolipid composition in a wide
variety of tumour cells with variable expression of ABC trans-
porter proteins.
In this study, we have characterized the sphingolipid compo-
sition of human HepG2 cells, stably transfected with MDR1-
GFP cDNA [10], compared to the composition in control cells,
stably transfected with GFP alone. The former cell line oﬀers
the advantage that its MDR1 overexpression is not the result
of a drug-induced selection procedure, which may result in
multiple cellular adaptations.
Our results show that glycolipids, especially LacCer, are ele-
vated in the MDR1 overexpressing cell line due to transcrip-
tional up-regulation of the enzyme lactosylceramide synthase
(LCS). This indirectly results in an increase in ganglioside
mass. As such, this study contributes to our knowledge of
MDR-associated sphingolipid metabolism. In addition, the
MDR1 overexpressing HepG2 cell line oﬀers a good model
to study the contribution of speciﬁc sphingolipids, including
gangliosides, to drug resistance of tumour cells.2. Materials and methods
2.1. Cell culture conditions
The HepG2/MDR1-GFP cell line was kindly provided by Dr. Toun-
sia Aı¨t Slimane and Prof. Dick Hoekstra. It is important to note that
this cell line was not obtained by clonal selection, but was established
from a mixed population of transfected cells (see [10] for details on the
transfection procedure). The HepG2/GFP control cell line was ob-
tained by a similar procedure, using the empty vector pEGFP-N1.
HepG2/MDR1-GFP and HepG2/GFP cells were grown in Dulbeccos
modiﬁed Eagles medium (DMEM, Invitrogen, Breda, The Nether-
lands) under standard incubator conditions (humidiﬁed atmosphere,
95% air, 5% CO2, 37 C). The medium was supplemented with 10%
heat-inactivated (56 C, 30 min) fetal calf serum (Bodinco, Alkmaar,
The Netherlands), 2 mM L-glutamine (Invitrogen), 100 units/ml peni-
cillin (Invitrogen), 100 lg/ml streptomycin (Invitrogen). For selection
800 lg/ml G418 (Invitrogen) was used.blished by Elsevier B.V. All rights reserved.
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Total RNA was isolated from cells using RNeasy Mini Kit (Qiagen
Valencia, CA) according to manufacturers instructions. Single
stranded cDNA was synthesized from RNA (1 lg) using Oligo
(dT)12–18 primer (0.5 lg), Superscript RT (200 units; Life Technologies,
Paisley, UK), 5· First Strand Buﬀer (4 ll), DTT (10 mM) and 0.5 mM
of each dNTP in a total volume of 20 ll. The RNA sample + Oligo
(dT)1218 primer were denatured at 65 C for 15 min and placed on
ice for 5 min, before adding it to the reaction. Reverse transcription
was performed for 1 h at 37 C and the samples were subsequently
heated for 5 min at 99 C to terminate the reverse transcription reac-
tion. Ampliﬁcation of mRNA for the household gene b-actin was used
as a control. PCR was performed with High Fidelity PCR Master Kit
(Roche Applied Science, Indianapolis, IN) according to manufac-
turers instructions. The ﬁnal reaction volume was 25 ll, containing
1 ll of cDNA and 250 nM of each PCR primer. PCR reactions were
run in a GeneAmp PCR System 9700 (Perkin–Elmer, Norwalk, CT).
The cycling program was 94 C for 30 s, 55 C for 30 s, 72 C for
30 s. The number of cycles was 40 for LCS and GM3 synthase and
20 for b-actin. The following primer sequences were employed: LCS:
sense 5 0-CTCCTCGCCTTCATCTTCTT-3 0, antisense 5 0-AGA-
ACTGCCACCTTCCATCT-3 0 (440 bp ampliﬁed product). GM3
synthase: sense 5 0-GGTTATTGGAAGCGGAGGAA-3 0, antisense
5 0-AAGACAACGGCAATGACACC-30 (456 bp ampliﬁed product).
b-actin: sense 5 0-AACACCCCAGCCATGTAC-3 0, antisense 5 0-ATG-
TCACGCACGATTTCC-3 0 (254 bp ampliﬁed product). PCR prod-
ucts (10 ll) were run in 1.8% agarose gels and visualized by
ethidium-bromide ﬂuorescence.
2.3. Equilibrium radiolabeling of cellular sphingolipids
Sphingolipid pools were metabolically radiolabeled to equilibrium as
described [9]. Cells were grown for 48 h (neutral sphingolipids) or 96 h
(gangliosides) in the presence of L-[U-14C]serine (1 lCi/ml; Amersham
International, Bercks, UK). In the case of inhibition of Pgp function,
10 lM cyclosporin A (CSA) was present during this 48 h incubation.
This concentration of CSA eﬃciently inhibited Pgp-mediated eﬄux,
as measured by Rhodamine 123 accumulation in the cells (data not
shown). Cells were then processed for either neutral sphingolipid or
ganglioside analysis.
2.4. Neutral sphingolipid analysis
Total lipid was extracted from the cells [11]. Acylglycerolipids
were hydrolyzed during an 1 h incubation at 37 C in CHCl3/
CH3OH (1:1, v/v) containing NaOH (0.1 M). The remaining lipids
were re-extracted and applied on high performance thin layer chro-
matography (HPTLC) plates (Merck, Amsterdam, The Netherlands).
Plates were developed in CHCl3/CH3OH/H2O (14:6:1, v/v/v) in the
ﬁrst dimension. Then the plates were sprayed with 2.5% H3BO3
(w/v) in CH3OH and developed in the second dimension, this time
using CHCl3/CH3OH/25% (w/v) NH4OH (13:7:1, v/v/v) as the mo-
bile phase. GlcCer, LacCer, and sphingomyelin (SM) containing
spots were scraped from the plates. Then the plates were developed
once more in the second dimension (contra direction), this time
using CHCl3/CH3COOH (9:1, v/v) as the mobile phase, followed
by scraping of the Cer containing spots. Radioactivity was measured
by scintillation counting (Packard Topcount microplate scintillation
counter, Meriden, CT, USA). Sphingolipid levels were expressed as
dps incorporated in a speciﬁc sphingolipid species per 103 dps of to-
tal lipid-incorporated radioactivity, as measured after the initial lipid
extraction.2.5. Ganglioside analysis
Gangliosides were isolated from 5 · 107 cells, as described [12,13].
Brieﬂy, pelleted cells were extracted in CHCl3/CH3OH (1:1; v/v)
and CHCl3/CH3OH (2:1; v/v). Pooled supernatants were dried (N2)
and the lipids were dissolved in CHCl3/CH3OH (1:1; v/v) and soni-
cated. After centrifugation and overnight storage at 20 C, the
supernatant was collected (total lipid extract). Aliquots of superna-
tant with equal lipid-phosphate content (6.7 lmol; [14]) were dried,
dissolved in diisopropylether/1-butanol (3:2; v/v), and 17 mM NaCl
was added. The aqueous phase was re-extracted with diisopropyle-
ther/1-butanol and subsequently lyophilized. Samples were dissolved
in CH3OH/H2O (1:1; v/v) and loaded onto pre-washed Sep-Pak C18
(Waters, Milford, MA, USA) cartridges. After rinsing (H2O), gan-gliosides were eluted with CH3OH and CHCl3/CH3OH (1:1; v/v).
The eluate was concentrated and loaded onto HPTLC plates, which
were developed in CHCl3/CH3OH/0.2% (w/v) CaCl2 (11:9:2; v/v/v).
HPTLC plates were stained with Ehrlich reagent in case of ganglio-
side mass analysis [15]. In case of radiolabeling, ganglioside contain-
ing spots were scraped and radioactivity was measured by
scintillation counting. Ganglioside levels were expressed as dps incor-
porated in a speciﬁc ganglioside species per 103 dps of total lipid-
incorporated radioactivity, as measured after the initial total lipid
extraction.
2.6. In situ sphingolipid conversion assay
Cells were trypsinized and plated into six wells-plates at a density
of 1 · 106 cells/well in medium with fetal calf serum. After 24 h the
cells were washed three times with medium without serum. Then
pre-warmed medium containing 900 pmol (0.045 lCi) of [14C]C6-Glc-
Cer (synthesized from lyso-GlcCer and [14C]C6-hydroxysuccinimide
ester as described in [9]) was added and the cells were incubated at
37 C for 3 h. Then the medium was collected and fresh medium con-
taining serum was added to the cells, followed by incubation for an-
other 7 h at 37 C. Reactions were terminated as follows: transfer of
the plates to ice, scraping of the cells in medium, extraction of
scraped cells together with the ﬁrst and second incubation media with
three volumes of C/M 2:1 (v/v). The extracted lipids were separated
by HPTLC. Plates were developed employing CHCl3/CH3OH/20%
(w/v) NH4OH (12:8:1, v/v/v) as mobile phase. After detection of
the spots by autoradiography and identiﬁcation with the aid of stan-
dards, the spots were scraped. The radioactivity content was mea-
sured by scintillation counting. The amount of product synthesized
was calculated according to % product · 900 pmol. Conversions were
corrected for the incubation time and expressed as pmol/106 cells/h.
In all experiments, one well was used as control for cell growth. In
this case, the cells were treated as above, but in the end a protein
determination was performed on the scraped cells, after washing
the cells to remove medium and serum.2.7. In vitro sphingolipid conversion assay
Cells were trypsinized and washed twice by centrifugation (5 min,
2000 · g), followed by resuspension in HBSS. The ﬁnal cell pellet
was re-suspended in ice-cold sucrose (250 mM), HEPES (10 mM),
EDTA (1 mM), pH 7.4, containing PMSF, pepstatinA, aprotinine,
benzamidine and leupeptin as protease inhibitors, to a concentration
of 107 cells/ml. The cells were homogenized by a freeze/thaw proce-
dure, involving ﬁve rounds of freezing/thawing, each consisting of
freezing the cells in liquid N2, followed by thawing the cells in a
37 C water bath. An equivalent of 106 cells was incubated with 1 nmol
(0.05 lCi) of [14C]C6-GlcCer in a total volume of 250 ll HBSS, con-
taining 0.5 mM UDP-galactose. After 3 h incubation, lipids were ex-
tracted with three volumes of C/M 2:1 (v/v) and analyzed as
described above.2.8. Statistical analysis
Results are presented as means ± S.D. (n P 3). Statistical analysis
was performed with the Students t-test, considering P < 0.05 signiﬁ-
cant.3. Results
3.1. HepG2/MDR1-GFP cells display an altered sphingolipid
composition compared to HepG2/GFP cells
The sphingolipid composition of HepG2/MDR1-GFP
and control HepG2/GFP cells was analyzed by equilibrium
radiolabeling [9]. The most prominent and highly signiﬁcant
diﬀerence was the high amount of LacCer observed in
MDR1-transfected cells compared to control cells (Table 1).
When HepG2/MDR1-GFP cells were treated with CSA to
inhibit Pgp activity, the LacCer level remained high and com-
parable to non-treated HepG2/MDR1-GFP cells (9.95 dps/
1000 dps; n = 2).
Table 1
Sphingolipid composition of HepG2/MDR1-GFP versus HepG2/GFP
cells
HepG2/GFP HepG2/MDR1-GFP P
Cer 9.30 ± 1.62 10.22 ± 3.33 0.69
GlcCer 6.45 ± 0.54 8.96 ± 0.89 0.014
LacCer 2.38 ± 0.41 9.04 ± 0.98 0.0004
GM3 0.72 ± 0.14 1.47 ± 0.09 0.0077
GM2 1.13 ± 0.37 1.71 ± 0.25 0.15
SM 88.04 ± 9.94 123.30 ± 21.52 0.062
Cells were incubated with L-[U-14C]serine (1 lCi/ml) for 48 h (neutral
sphingolipids) or 96 h (gangliosides) and sphingolipids were isolated
and analyzed. Values are expressed as dps of a speciﬁc sphingolipid per
1000 dps of the total radiolabeled lipid pool. Data represent the
means ±S.D. of three independent experiments. P-values were calcu-
lated with the Students t-test (considering P < 0.05 signiﬁcant).
Fig. 2. Ganglioside mass analysis of HepG2/MDR1-GFP and control
HepG2/GFP cells. Gangliosides were isolated from aliquots of cells
with equal lipid-phosphate content and separated on HPTLC plates,
followed by Ehrlich staining. Shown are representative results from
three independent experiments.
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MDR1-GFP cells
Next we tested whether the increased level of LacCer ob-
served in HepG2/MDR1-GFP cells was the result of in-
creased activity of the enzyme LCS, which is directly
responsible for its biosynthesis. LacCer biosynthesis was mea-
sured in intact cells using a radiolabeled precursor, [14C]-C6-
GlcCer [9]. Indeed, in situ LCS activity was 4.5-fold and
highly signiﬁcantly increased in HepG2/MDR1-GFP cells
compared to control HepG2/GFP cells (Table 2). Also, when
LacCer biosynthesis was measured in vitro, i.e. in broken
cells, the activity was highly signiﬁcantly increased in
HepG2/MDR1-GFP cells, be it with a factor 2.3 (Table 2).
In accordance, the mRNA encoding LCS was up-regulated
in HepG2/MDR1-GFP cells (Fig. 1).Fig. 1. Expression levels of LCS and GM3 synthase mRNA in HepG2/
MDR1-GFP and control HepG2/GFP cells. mRNA expression levels
were determined by RT-PCR, using speciﬁc primers. The PCR
products were run in a 1.8% agarose gel. As a control, mRNA for
the household gene b-actin was used. Shown are representative results
from three independent experiments.
Table 2
Sphingolipid conversion in situ and in vitro
LacCer synthesis HepG2/GFP HepG2/MDR1-GFP P
In situ 2.13 ± 0.49 9.45 ± 0.35 0.0001
In vitro 3.25 ± 0.58 7.24 ± 0.53 0.0002
Either intact cells or broken cells were incubated with [14C]C6-GlcCer
and its conversion to [14C]C6-LacCer was measured. Values are ex-
pressed as pmol/106 cells/h of synthesized [14C]C6-LacCer. Data rep-
resent the means ± S.D. of three independent experiments. P-values
were calculated with the Students t-test (considering P < 0.05 signiﬁ-
cant).3.3. Ganglioside expression is increased in HepG2/MDR1-GFP
cells
The increased activity of the LCS and the ensuing higher lev-
els of LacCer also resulted in an increased mass of the down-
stream products of LacCer, i.e. gangliosides. In HepG2 cells,
the gangliosides GM3 and GM2 were detected. Both were more
abundantly expressed in HepG2/MDR1-GFP cells compared
to HepG2/GFP cells, when analyzed by mass (Fig. 2). When
analyzed by radiolabel incorporation, the GM3 level was two-
fold and signiﬁcantly increased in HepG2/MDR1-GFP cells
(Table 1), while the increase in GM2 level did not reach signif-
icance. Although the level of GM3 was increased, the expres-
sion of GM3 synthase mRNA was not higher in HepG2/
MDR1-GFP cells compared to HepG2/GFP cells (Fig. 1).4. Discussion
It has been shown that in vitro drug-selected MDR1 [2,3,5,9]
and MRP1 [6] overexpressing tumour cell lines display en-
hanced levels of the sphingolipid GlcCer. Moreover, some of
these studies showed that in addition to changes in the level
of GlcCer, other sphingolipid levels are altered in MDR tu-
mour cells, however in a cell type dependent fashion. In the
present study, we analyzed the composition of sphingolipids
in HepG2 human liver tumour cells, stably transfected with
MDR1-GFP cDNA (HepG2/MDR1-GFP cells) and com-
pared to control HepG2/GFP cells, stably transfected with
cDNA encoding GFP alone. This model oﬀers the advantage
that multiple cellular adaptations due to drug-induced selec-
tion are avoided. In this model, an increased LacCer level in
MDR1 overexpressing cells was the most prominent diﬀerence,
while the level of the LacCer-derived ganglioside GM3 was
also signiﬁcantly elevated in these cells.
Increased expression of the glycolipids LacCer and its down-
stream product globotriaosylceramide was observed in
MDR1-transfected MDCK cells [16]. The authors proposed
that the overexpressed Pgp was partly localized at the Golgi
and there mediated GlcCer translocation across the bilayer,
from the cytosolic face to the lumen of the Golgi. This GlcCer
provided increased substrate for the biosynthesis of LacCer
and globotriaosylceramide. Such a mechanism is unlikely in
our HepG2/MDR1-GFP model. First, MDR1-GFP was not
detectable in the Golgi (data not shown, cf. [10]). Second,
CSA did not reduce the high levels of LacCer in HepG2/
MDR1-GFP cells, as would be expected when Pgp-mediated
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strate availability to the LCS, we show that the high LacCer
level in MDR1 overexpressing cells is the direct result of en-
hanced LCS activity. The activity was highly signiﬁcantly in-
creased when measured in situ, i.e. in intact cells. However,
the net in situ conversion of GlcCer to LacCer could have been
inﬂuenced by diﬀerential catabolism of GlcCer and/or LacCer
in MDR1 overexpressing versus control cells. Therefore, we
also measured LCS activity in vitro, i.e. in broken cells, and
showed a highly signiﬁcant increase in MDR1 overexpressing
cells. The increased LCS activity in turn was due to up-regula-
tion of LCS on the transcriptional level. Thus, we have shown
up-regulation of LCS at three levels, i.e. increased mRNA cod-
ing for LCS, increased LCS in situ and in vitro activity and in-
creased LacCer levels in MDR overexpressing cells.
Interestingly, in another MDR1 model, i.e. 2780AD cells
which overexpressed MDR1 upon selection with doxorubicin,
decreased levels of LacCer were observed [9]. In the latter case,
this was due to decreased substrate availability to the LCS due
to uncoupling of GCS and LCS in the Golgi apparatus. The
conclusion that opposite eﬀects of MDR1 overexpression on
LacCer levels occur in diﬀerent cell models, while these eﬀects
are based on entirely diﬀerent molecular mechanisms, under-
scores the importance of studying MDR-associated changes
in sphingolipid composition in a wide variety of tumour cells
with variable expression of ABC transporter proteins. In this
respect, it is important to note that up-regulation of MDR1
was achieved in diﬀerent ways in HepG2/MDR1-GFP cells
and 2780AD cells, i.e. by transfection and drug-induced
selection, respectively.
Recently, up-regulation of gangliosides was reported in fen-
retinide-adapted A2780 cells as well, and was correlated with
fenretinide resistance [17]. In this case up-regulation occurred
at the level of GM3 biosynthesis, based on transcriptional up-
regulation of GM3 synthase. HepG2/MDR1-GFP, on the
other hand, did not display transcriptional up-regulation of
GM3 synthase, suggesting that the increased level of GM3 li-
pid in this case was due to increased availability of the sub-
strate LacCer. However, changes in GM3 synthase protein
expression and/or activity cannot be excluded based on our
results. A functional role for gangliosides in MDR is only re-
cently emerging. Certain gangliosides (GM3, GD3) may be di-
rectly involved in MDR by modulation of Pgp function
through alteration of its phosphorylation state [18]. Due to
the novelty of this particular research area and the limited
studies and results available, a consistent picture concerning
the contribution of speciﬁc gangliosides to MDR has not
yet emerged.
In conclusion, the HepG2/MDR1-GFP human hepatoma
cell line reveals a novel mechanism of MDR-associated
changes in glycolipid biosynthesis through up-regulation of
LCS activity, in concert with MDR1 overexpression. This does
not involve a potential lipid translocation property of Pgp, but
occurs through LCS up-regulation at the transcriptional level.References
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